Treating non-small cell lung cancer: What do patients PREFER

Meredith Smith; Serena Oliveri; Monica Casiraghi

doi:10.5281/zenodo.6260511

February 24, 2022 Other Open Access

Treating non-small cell lung cancer: What do patients PREFER

Meredith Smith; Serena Oliveri; Monica Casiraghi

DCAT Export

<?xml version='1.0' encoding='utf-8'?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:adms="http://www.w3.org/ns/adms#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:dctype="http://purl.org/dc/dcmitype/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:duv="http://www.w3.org/ns/duv#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:frapo="http://purl.org/cerif/frapo/" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:gsp="http://www.opengis.net/ont/geosparql#" xmlns:locn="http://www.w3.org/ns/locn#" xmlns:org="http://www.w3.org/ns/org#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:prov="http://www.w3.org/ns/prov#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:vcard="http://www.w3.org/2006/vcard/ns#" xmlns:wdrs="http://www.w3.org/2007/05/powder-s#">
  <rdf:Description rdf:about="https://doi.org/10.5281/zenodo.6260511">
    <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://doi.org/10.5281/zenodo.6260511</dct:identifier>
    <foaf:page rdf:resource="https://doi.org/10.5281/zenodo.6260511"/>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Meredith Smith</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Alexion</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Serena Oliveri</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>European Institute of Oncology</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Monica Casiraghi</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>European Institute of Oncology</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:title>Treating non-small cell lung cancer: What do patients PREFER</dct:title>
    <dct:publisher>
      <foaf:Agent>
        <foaf:name>Zenodo</foaf:name>
      </foaf:Agent>
    </dct:publisher>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2022</dct:issued>
    <dcat:keyword>Plain language summary</dcat:keyword>
    <dcat:keyword>Case study</dcat:keyword>
    <frapo:isFundedBy rdf:resource="info:eu-repo/grantAgreement/EC/H2020/115966/"/>
    <schema:funder>
      <foaf:Organization>
        <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10.13039/100010661</dct:identifier>
        <foaf:name>European Commission</foaf:name>
      </foaf:Organization>
    </schema:funder>
    <dct:contributor>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Rosanne Janssens</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>KU Leuven</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:contributor>
    <dct:contributor>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Isabelle Huys</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>KU Leuven</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:contributor>
    <dct:contributor>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Ian Smith</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>University Medical Centre Utrecht</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:contributor>
    <dct:contributor>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Charis Girvalaki</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>European Cancer Patient Coalition</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:contributor>
    <dct:contributor>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Ardine de Wit</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>University Medical Centre Utrecht</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:contributor>
    <dct:contributor>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Jorien Veldwijk</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Erasmus University Rotterdam</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:contributor>
    <dct:contributor>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Lucilla Lanzoni</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>European Institute of Oncology</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:contributor>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2022-02-24</dct:issued>
    <owl:sameAs rdf:resource="https://zenodo.org/record/6260511"/>
    <adms:identifier>
      <adms:Identifier>
        <skos:notation rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://zenodo.org/record/6260511</skos:notation>
        <adms:schemeAgency>url</adms:schemeAgency>
      </adms:Identifier>
    </adms:identifier>
    <dct:isVersionOf rdf:resource="https://doi.org/10.5281/zenodo.6260510"/>
    <dct:isPartOf rdf:resource="https://zenodo.org/communities/prefer"/>
    <dct:description>&lt;p&gt;We wanted to learn about lung cancer patients&amp;rsquo;&amp;nbsp;preferences for new treaments, and what they considered to be the maximum acceptable risk, and the minimum acceptable benefit of a treatment.&lt;/p&gt;</dct:description>
    <dct:accessRights rdf:resource="http://publications.europa.eu/resource/authority/access-right/PUBLIC"/>
    <dct:accessRights>
      <dct:RightsStatement rdf:about="info:eu-repo/semantics/openAccess">
        <rdfs:label>Open Access</rdfs:label>
      </dct:RightsStatement>
    </dct:accessRights>
    <dct:license rdf:resource="https://creativecommons.org/licenses/by/4.0/legalcode"/>
    <dcat:distribution>
      <dcat:Distribution>
        <dcat:accessURL rdf:resource="https://doi.org/10.5281/zenodo.6260511"/>
        <dcat:byteSize>795397</dcat:byteSize>
        <dcat:downloadURL rdf:resource="https://zenodo.org/record/6260511/files/Treating non-small cell lung cancer - What do patients PREFER.pdf"/>
        <dcat:mediaType>application/pdf</dcat:mediaType>
      </dcat:Distribution>
    </dcat:distribution>
  </rdf:Description>
  <foaf:Project rdf:about="info:eu-repo/grantAgreement/EC/H2020/115966/">
    <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">115966</dct:identifier>
    <dct:title>Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966</dct:title>
    <frapo:isAwardedBy>
      <foaf:Organization>
        <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10.13039/100010661</dct:identifier>
        <foaf:name>European Commission</foaf:name>
      </foaf:Organization>
    </frapo:isAwardedBy>
  </foaf:Project>
</rdf:RDF>

185

120

views

downloads

See more details...

	All versions	This version
Views	185	185
Downloads	120	120
Data volume	95.4 MB	95.4 MB
Unique views	169	169
Unique downloads	106	106

More info on how stats are collected.

Indexed in

Publication date:

February 24, 2022

DOI:

Keyword(s):

Plain language summary Case study

Grants:

European Commission:

PREFER - Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 (115966)

Communities:

PREFER - Why, when and how to assess and use patient preferences in medical product decision-making

License (for files):

Creative Commons Attribution 4.0 International

Versions

Version 1 10.5281/zenodo.6260511

Feb 24, 2022

Cite all versions? You can cite all versions by using the DOI 10.5281/zenodo.6260510. This DOI represents all versions, and will always resolve to the latest one. Read more.

Treating non-small cell lung cancer: What do patients PREFER

DCAT Export

Versions

Share

Cite as

Export

About

Blog

Help

Developers

Contribute

Treating non-small cell lung cancer: What do patients PREFER

DCAT Export

Zenodo DOI Badge

DOI

10.5281/zenodo.6260511

Markdown

[![DOI](https://zenodo.org/badge/DOI/10.5281/zenodo.6260511.svg)](https://doi.org/10.5281/zenodo.6260511)

reStructedText

.. image:: https://zenodo.org/badge/DOI/10.5281/zenodo.6260511.svg :target: https://doi.org/10.5281/zenodo.6260511

HTML

<a href="https://doi.org/10.5281/zenodo.6260511"><img src="https://zenodo.org/badge/DOI/10.5281/zenodo.6260511.svg" alt="DOI"></a>

Image URL

https://zenodo.org/badge/DOI/10.5281/zenodo.6260511.svg

Target URL

https://doi.org/10.5281/zenodo.6260511

Versions

Share

Cite as

Export